MED LIFE GROUP

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2023

PREPARED IN ACCORDANCE WITH INTERNATIONAL FINANCIAL REPORTING STANDARDS AS

ADOPTED BY EUROPEAN UNION

Name of the issuing company: MED LIFE S.A.

Registered Office: Bucharest, 365 Calea Griviței, district 1, Romania

Fax no.: 0040 374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: RON 132.870.492

Regulated market on which the issued securities are traded: Bucharest Stock Exchange

CONTENTS:

PAGE:

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

2

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

3

CONSOLIDATED STATEMENT OF CASH FLOWS

4

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

5 - 6

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

7 - 65

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language.

MED LIFE GROUP

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

December 31,

December 31,

Note

2023

2022

ASSETS

Non-current Assets

Goodwill

4

445,395,617

368,672,606

Intangible assets

5

118,906,011

100,192,265

Property, plant and equipment

5

1,101,015,115

828,501,060

Right-of-use asset

13

396,569,537

306,413,389

Other financial assets

5.4

40,942,540

82,810,704

Total Non-Current Assets

2,102,828,820

1,686,590,024

Current Assets

Inventories

6

109,657,497

98,770,370

Trade Receivables

7.1.

261,664,410

221,358,860

Other assets

7.2.

50,216,242

44,362,334

Cash and cash equivalents

8

100,271,093

89,068,154

Prepayments

9

11,699,369

11,826,587

Total Current Assets

533,508,611

465,386,305

TOTAL ASSETS

2,636,337,431

2,151,976,329

LIABILITIES & SHAREHOLDER'S EQUITY

Non-Current Liabilities

Lease liability

13,14

309,158,946

225,175,340

Other long term debt

11

47,775,013

21,657,277

Interest-bearing loans and borrowings

14

1,040,639,641

803,273,659

Deferred tax liability

26

44,897,775

44,250,160

Total Non-Current Liabilities

1,442,471,375

1,094,356,436

Current Liabilities

Trade and other payables

10

404,553,771

335,356,742

Overdraft

14

29,835,472

27,801,016

Current portion of lease liability

13,14

99,589,187

77,141,698

Current portion of interest-bearing loans and borrowings

14

82,297,342

55,695,054

Current tax liabilities

26

321,242

814,508

Provisions

12

11,116,544

9,783,326

Other liabilities

11

71,960,475

68,989,304

Total Current Liabilities

699,674,033

575,581,648

TOTAL LIABILITIES

2,142,145,408

1,669,938,084

SHAREHOLDER'S EQUITY

Share capital and Share premium

15

132,562,338

83,812,556

Treasury shares

(681,892)

(3,219,219)

Reserves

17

212,560,216

204,591,243

Retained earnings

70,850,636

131,596,254

Equity attributable to owners of the Group

415,291,298

416,780,834

Non-controlling interests

18

78,900,725

65,257,411

TOTAL EQUITY

494,192,023

482,038,245

TOTAL LIABILITIES AND EQUITY

2,636,337,431

2,151,976,329

Mihail Marcu,

Alina Irinoiu,

CEO

CFO

The accompanying notes are an integral part of the consolidated financial statemetns. | page 2

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

12 months ended December 31,

Note

2023

2022

Revenue from contracts with customers

19

2,210,435,349

1,795,432,748

Other operating income

20

11,300,635

14,118,061

Operating Income

2,221,735,984

1,809,550,809

Consumable materials and repair materials

21

(389,887,326)

(311,233,127)

Third party expenses

(625,309,108)

(468,196,458)

Salary and related expenses

23

(543,024,486)

(442,897,905)

Social contributions

23

(19,480,725)

(15,852,088)

Depreciation, amortization and impairment of fixed assets

5,13

(197,390,915)

(152,410,751)

Impairment losses and gains (including reversals of

7

(2,688,649)

(4,851,599)

impairment losses)

Commodities expenses

22

(208,134,799)

(209,975,320)

Other operating expenses

(144,302,612)

(109,903,888)

Operating expenses

(2,130,218,620)

(1,715,321,136)

Operating Profit

24

91,517,364

94,229,673

Finance cost

(82,170,695)

(42,489,150)

Interest income

24

3,423,077

-

Other financial income

24

1,221,841

-

Other financial expenses

24

(9,692,103)

(2,183,221)

Financial result

24

(87,217,880)

(44,672,371)

Profit Before Tax

26

4,299,484

49,557,301

Income tax expense

(8,464,341)

(12,124,746)

Profit After Tax

(4,164,857)

37,432,555

Owners of the Group

18

3,684,292

32,173,072

Non-controlling interests

(7,849,149)

5,259,483

Earnings per share

16

Basic earnings per share

0.007

0.061

Diluted earnings per share

16

0.007

0.061

Other comprehensive income items that will not

be reclassified to profit or loss

Revaluation of land and buildings Deferred tax on other comprehensive income components TOTAL OTHER COMPREHENSIVE INCOME

Total other comprehensive income attributable Owners of the Group

Non-controlling interests

  • 66,292,412
  • (10,606,786)
  • 55,685,626
  • 54,012,309
  • 1,673,317

TOTAL COMPREHENSIVE INCOME

(4,164,857)

93,118,181

Total comprehensive income attributable to:

Owners of the Group

3,684,292

86,185,381

Non-controlling interests

18

(7,849,149)

6,932,800

*The amounts for 2022 on Basic and diluted earnings per share were properly restated to reflect the bonus issue that took place in 2023, while for the weighted average number of shares for 2023, the bonus issue is reflected as if the shares were outstanding from the beginning of the year (1st of January 2022) - please also refer to Note 16.

Mihail Marcu,

Alina Irinoiu,

CEO

CFO

The accompanying notes are an integral part of the consolidated financial statemetns. | page 3

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

12 months ended December 31,

Note

2023

2022

Profit before tax

26

4,299,484

49,557,301

Adjustments for

Depreciation, amortization and impairment of fixed assets

5,13

197,390,915

152,410,751

Provisions for liabilities and charges

838,338

625,545

Interest revenue

24

(3,423,077)

(1,261,843)

Interest expense

24

82,170,695

42,489,150

Allowance for expected credit losses and receivables written-

2,688,649

4,851,599

off

7

Financial Discounts

2,850

-

Other non-monetary gains

20

-

(6,671,334)

Unrealized exchange loss

24

9,692,103

3,501,567

Other income

24

(1,221,841)

-

Operating cash flow before working capital changes

292,438,116

245,502,736

(Increase) in accounts receivable

(61,538,538)

(36,113,768)

(Increase) in inventories

(5,962,324)

(12,198,174)

Decrease in prepayments

855,343

156,186

Increase in accounts payable

30,126,281

31,216,630

Cash generated from working capital changes

(36,519,238)

(16,939,126)

Cash generated from operations

255,918,878

228,563,610

Interest Paid

14

(61,662,770)

(32,377,399)

Interest received

3,423,077

1,261,843

Income Tax Paid

26

(14,171,759)

(12,832,118)

Net cash from operating activities

183,507,426

184,615,936

Acquisition of subsidiary net of cash acquired and advances

(66,544,664)

(316,554,749)

for acquisition of subsidiaries

4,27

Purchase of intangible assets

5

(18,639,571)

(20,243,591)

Purchase of property, plant and equipment

5

(201,317,379)

(149,107,846)

Net cash used in investing activities

(286,501,614)

(485,906,186)

Proceeds from loans

14

284,583,155

411,844,392

Payment of loans

14

(77,658,667)

(73,446,528)

Payment of principal portion of lease liabilities

14

(83,856,889)

(69,381,986)

Dividends paid to NCI

18

(1,397,470)

(136,861)

Payments for purchase of treasury shares

(488,718)

(7,851,825)

Additional participation interest acquired

4,27

(6,984,284)

(6,527,676)

Net cash from/(used in) financing activities

114,197,127

254,499,516

Net change in cash and cash equivalents

11,202,939

(46,790,734)

Cash and cash equivalents beginning of the period

89,068,154

135,858,888

Cash and cash equivalents end of the period

100,271,093

89,068,154

Mihail Marcu,

Alina Irinoiu,

CEO

CFO

The accompanying notes are an integral part of the consolidated financial statemetns. | page 4

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

Balance as at December 31, 2022 Profit of the year

Total comprehensive income

Recognition of other reserves for fiscal purposes (legal reserves) (Note 17) Recognition of other reserves (Note 17) Increase in share capital through incorporation of reserves (Note 15)

Additional non-controlling interest arising as of result of business combinations (Note 18)

Subsequent acquisition of NCI (Note 18)

Distribution of dividends (Note 18)

Increase from own shares acquisition (Note 15)

Net release of own shares used for acquiring additional NCI (Note 15)

Increase in premiums due to difference btw FV and cost of own shares when the change was made (Note 15)

Balance as at December 31, 2023

Treasury

Share

Legal reserves

Revaluation

Accumulated

Attributable to

Non-

Share Capital

and other

owners of the

controlling

Total Equity

shares

premium

Reserve

Results

reserves

Group

interests

33,217,623

(3,219,219)

50,594,933

55,094,194

149,497,049

131,596,254

416,780,834

65,257,411

482,038,245

-

-

-

-

-

3,684,292

3,684,292

(7,849,149)

(4,164,857)

-

-

-

-

-

3,684,292

3,684,292

(7,849,149)

(4,164,857)

-

-

-

821,321

-

(821,321)

-

-

-

-

-

-

7,147,652

-

(7,147,652)

-

-

-

99,652,869

-

(50,594,933)

-

-

(49,057,937)

-

-

-

-

-

-

-

-

-

-

27,511,565

27,511,565

-

-

-

-

-

(7,403,000)

(7,403,000)

(4,118,681)

(11,521,681)

-

-

-

-

-

-

-

(1,900,421)

(1,900,421)

-

(488,718)

-

-

-

-

(488,718)

-

(488,718)

-

3,026,045

-

-

-

-

3,026,045

-

3,026,045

-

-

(308,155)

-

-

-

(308,155)

-

(308,155)

132,870,492

(681,892)

(308,155)

63,063,167

149,497,049

70,850,636

415,291,298

78,900,725

494,192,023

Please refer to Note 18 for transactions during 2023 with Non-controlling interest.

Mihail Marcu,

Alina Irinoiu,

CEO

CFO

The accompanying notes are an integral part of the consolidated financial statemetns. | page 5

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

Balance as at December 31, 2021

Profit of the year Revaluation of Land and Buildings (Note 5, 17) Deferred tax related to other elements of the overall result (Note 26) Total comprehensive income Recognition of other reserves for fiscal purposes (legal reserves) (Note 17)

Recognition of other reserves (Note 17)

Additional non-controlling interest arising as of result of business combinations (Note 18)

Subsequent acquisition of NCI (Note 18)

Increase from own shares acquisition (Note 15)

Net release of own shares used for acquiring additional NCI (Note 15)

Increase in premiums due to difference between fair value and cost of own shares when the exchange was made (Note 15)

Balance as at December 31, 2022

Treasury

Share

Legal reserves

Revaluation

Accumulated

Attributable to

Non-

Share Capital

and other

owners of the

controlling

Total Equity

shares

premium

Reserve

Results

reserves

Group

interests

33,217,623

(4,015,977)

49,177,468

41,850,760

95,484,740

122,394,796

338,109,410

43,295,149

381,404,558

-

-

-

-

-

32,173,072

32,173,072

5,259,483

37,432,555

-

-

-

-

64,300,368

-

64,300,368

1,992,044

66,292,412

-

-

-

-

(10,288,059)

-

(10,288,059)

(318,727)

(10,606,786)

-

-

-

-

54,012,309

32,173,072

86,185,381

6,932,800

93,118,181

-

-

-

885,378

-

(885,378)

-

-

-

-

-

-

12,358,056

-

(12,358,056)

-

-

-

-

-

-

-

-

-

-

21,895,097

21,895,097

-

-

-

-

-

(9,728,180)

(9,728,180)

(6,865,635)

(16,593,814)

-

(7,851,825)

-

-

-

-

(7,851,825)

-

(7,851,825)

-

8,648,583

-

-

-

-

8,648,583

-

8,648,583

-

-

1,417,465

-

-

-

1,417,465

-

1,417,465

33,217,623

(3,219,219)

50,594,933

55,094,194

149,497,049

131,596,254

416,780,834

65,257,411

482,038,245

During 2022, the Group performed the revaluation of Land and Buildings owned - please refer to Note 5 and Note 26 for relevant disclosures and overall impact.

Mihail Marcu,

Alina Irinoiu,

CEO

CFO

The accompanying notes are an integral part of the consolidated financial statemetns. |

page 6

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

1. DESCRIPTION OF THE BUSINESS

Med Life S.A. ("MedLife" or the "Parent Company" or the "Company") is a joint-stock company incorporated in 1996, in accordance with the laws and regulations of Romania, with headquarters in 365 Calea Grivitei, Bucharest, with a share capital of RON 132,870,492, having a nominal share value of 0.25 RON.

The Company's activity resides in conducting healthcare services through medical centres with national coverage.

MedLife, together with its subsidiaries ("MedLife Group" or the "Group"), is offering a large range of medical services, through a network of 35 hyperclinics, 68 clinics, 15 hospitals - located in Bucharest, Arad, Sibiu, Brasov, Cluj, Ploiesti and Pitesti, 39 laboratories, 21 pharmacies and 18 dental clinics. The Group has also over 170 private clinic partners around Romania.

Medlife is the leading private health care services provider in Romania in terms of sales, having a significant market share at a national level.

The ultimate parent of the Group is Med Life SA. In accordance with the provisions of the Law no. 129/2019, the Group has identified the following controlling parties:

The Marcu family:

  1. Mr. Mihail Marcu, considering his quality of shareholder of the Company, which holds a percentage of 14.7672% of its share capital;
  2. Mr. Nicolae Marcu, considering his quality of shareholder of the Company, which holds a percentage of 10.4127% of its share capital;
  3. Mrs. Mihaela Gabriela Cristescu, considering her quality of shareholder of the Company, which holds a percentage of 14.0443% of its share capital.

Considering the family relations between the persons mentioned above, namely the fact that Mr. Mihail Marcu and Mr. Nicolae Marcu are the sons of Mrs. Mihaela Gabriela Cristescu, and the fact that together they own more than 25% of the total share capital of the company, for to pursue the purpose of the law, even if the law refers to the natural person, this expression of the law does not exclude the hypothesis of natural persons acting together, to the extent that it is established that they control the company together and are the final beneficiaries of its activity.

The entities part of MedLife Group as at December 31, 2023 and December 31, 2022 are as follows (ownership percentage):

The accompanying notes are an integral part of the consolidated financial statemetns. | page 7

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

No.

1

2 3

4

5 6

7

8 9 10 11 12

13

14 15 16 17

18

19 20 21 22

23

24 25 26

27

28 29

30

31

32 33 34 35

Entity

Policlinica de Diagnostic Rapid SA Medapt SRL (indirect)* Histo SRL (indirect)* Policlinica de Diagnostic Rapid Medis SRL (indirect)*

Bahtco Invest SRL** Med Life Ocupational SRL

Pharmalife-Med SRL

Med Life Broker de Asigurare si Reasigurare SRL Accipiens SA Genesys Medical Clinic SRL (indirect)* Bactro SRL (indirect)* Transilvania Imagistica SA (indirect)*

Biofarm Farmec SRL (indirect)*

RUR Medical SRL (indirect)** Biotest Med SRL Vital Test SRL Centrul Medical Sama SA Ultratest SA (direct and indirect)* Diamed Center SRL Prima Medical SRL Stem Cells Bank SA Dent Estet Clinic SA Green Dental Clinic SRL (indirect)* Dentist 4 Kids SRL (indirect)* Dent A Porter SRL (indirect)* Dentestet Kids SRL (indirect)* Aspen Laborator Dentar SRL (indirect)* Centrul Medical Panduri SA Almina Trading SA Anima Specialty Medical Services SRL Anima Promovare si Vanzari SRL (indirect)* Valdi Medica SA Clinica Polisano SRL Solomed Clinic SA Solomed Plus SRL (indirect)*

Main activity

Location

31December

31 December

2023

2022

Medical Services

Brasov, Romania

83%

83%

Medical Services

Brasov, Romania

83%

83%

Medical Services

Brasov, Romania

49.8%

49.8%

Medical Services

Sfantu Gheorghe,

66.4%

66.4%

Romania

Development of building

Bucharest, Romania

100%

100%

projects

Medical Services

Bucharest, Romania

100%

100%

Distribution of Pharmaceutical

Bucharest, Romania

100%

100%

Products in specialised stores

Insurance broker

Bucharest, Romania

99%

99%

Rental activities

Arad, Romania

83%

83%

Medical Services

Arad, Romania

83%

83%

Medical Services

Deva, Romania

83%

83%

Medical Services

Oradea, Romania

83%

83%

Distribution of Pharmaceutical

Arad, Romania

100%

100%

Products in specialised stores

Medical Services

Brasov, Romania

83%

83%

Medical Services

Bucharest, Romania

100%

100%

Medical Services

Iasi, Romania

100%

100%

Medical Services

Craiova, Romania

90%

90%

Medical Services

Craiova, Romania

92.2%

92.2%

Medical Services

Bucharest, Romania

100%

100%

Medical Services

Craiova, Romania

100%

100%

Medical Services

Timisoara, Romania

100%

100%

Dental healthcare

Bucharest, Romania

65%

60%

Dental healthcare

Bucharest, Romania

33.2%

31%

Dental healthcare

Bucharest, Romania

65%

60%

Dental healthcare

Bucharest, Romania

33.5%

31%

Dental healthcare

Bucharest, Romania

34.4%

32%

Dental healthcare

Bucharest, Romania

48.8%

45%

Medical Services

Bucharest, Romania

100%

100%

Medical Services

Targoviste, Romania

90%

90%

Medical Services

Bucharest, Romania

100%

100%

Medical Services

Bucharest, Romania

100%

100%

Medical Services

Cluj, Romania

55%

55%

Medical Services

Sibiu, Romania

100%

100%

Medical Services

Pitesti, Romania

80%

80%

Medical Services

Pitesti, Romania

80%

80%

The accompanying notes are an integral part of the consolidated financial statemetns. | page 8

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

MED LIFE GROUP

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED DECEMBER 31, 2023

(all amounts are expressed in RON, unless otherwise specified)

No.

Entity

Main activity

Location

36

Ghencea Medical Center SA

Medical Services

Bucharest, Romania

37

Sfatul medicului SRL

Medical Platform

Bucharest, Romania

38

RMC Dentart (indirect)*

Dental healthcare

Budapesta, Ungaria

39

RMC Medical (indirect)*

Medical Services

Budapesta, Ungaria

40

RMC Medlife

Holding

Budapesta, Ungaria

41

Badea Medical SRL

Medical Services

Cluj, Romania

42

Oncoteam Diagnostic SRL**

Medical Services

Bucharest, Romania

43

Centrul medical Micromedica

Medical Services

Piatra Neamt,

SRL

Romania

44

Micromedica Targu Neamt

Medical Services

Targu Neamt,

SRL (indirect)*

Romania

45

Micromedica Bacau SRL

Medical Services

Bacau, Romania

(indirect)*

46

Micromedica Roman SRL

Medical Services

Roman, Romania

(indirect)*

47

Medrix Center SRL

Medical Services

Roznov, Romania

(indirect)*

48

Spitalul Lotus SRL

Medical Services

Ploiesti, Romania

49

Labor Maricor SRL (indirect)*

Medical Services

Bacau, Romania

50

Centrul Medical Matei

Medical Services

Bucharest, Romania

Basarab SRL (indirect)*

51

Pharmachem Distributie SRL

Distribution of

Bucharest, Romania

Pharmaceutical Products

Distribution of

52 CED Pharma SRL (indirect)* Pharmaceutical Products in Bucharest, Romania

specialised stores

Leti Pharm 2000 SRL

Distribution of

53

Pharmaceutical Products in

Bucharest, Romania

(indirect)*

specialised stores

Distribution of

54

Monix Pharm SRL (indirect)*

Pharmaceutical Products in

Bucharest, Romania

specialised stores

55

KronDent SRL (indirect)*

Dental healthcare

Brasov, Romania

56

Medica SA

Medical Services

Sibiu, Romania

57

Dent Estet Ploiesti SRL

Dental healthcare

Ploiesti, Romania

(indirect)*

58

The Lab Stomestet SRL

Dental healthcare

Cluj, Romania

(indirect)*

59

Stomestet SRL (indirect)*

Dental healthcare

Cluj, Romania

60

Stomestet Plus SRL

Dental healthcare

Cluj, Romania

(indirect)*

61

Costea Digital Dental SRL

Dental healthcare

Oradea, Romania

(indirect)*

62

Expert Med Centrul Medical

Medical Services

Galati, Romania

Irina (indirect)*

63

MNT Healthcare Europe SRL

Medical Services

Ilfov, Romania

64

MNT Asset Management SRL

Holding

Bucharest, Romania

(indirect)*

65

Clinica Life-Med SRL

Medical Services

Bucharest, Romania

(indirect)*

66

Pro Life Clinics SRL

Medical Services

Iasi, Romania

(indirect)*

67

Onco Card SRL (indirect)*

Medical Services

Brasov, Romania

68

Onco Card Invest SRL

Holding

Brasov, Romania

(indirect)*

69

Tomorad Expert SRL

Medical Services

Sfantu Gheorghe,

(indirect)*

Romania

70

IT Repair SRL (indirect)*

Medical Services

Targu Mures,

Romania

31December 31 December

20232022

100%

100%

100%

100%

87.6%

81.3%

87.6%

81.3%

87.6%

81.3%

65%

65%

100%

79%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

100%

75%

75%

100%

100%

100%

100%

100%

100%

39%

36%

60%

60%

33.2%

30.6%

39%

36%

39%

36%

39%

36%

38.4%

36%

76%

76%

50%

50%

50%

50%

100%

100%

60%

60%

83%

83%

83%

83%

66.4%

66.4%

49.8%

49.8%

The accompanying notes are an integral part of the consolidated financial statemetns. | page 9

The English version of the consolidated financial statements represents a translation of the original consolidated financial statemetns issued in Romanian language

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Med Life SA published this content on 29 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2024 19:49:22 UTC.